Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,595,000 | 1,927,000 | 2,907,000 | 3,205,000 | 6,848,000 |
| Marketable Securities | 3,204,000 | 5,098,000 | 5,697,000 | 6,697,000 | 3,879,000 |
| Receivables | 184,000 | 358,000 | 892,000 | 1,385,000 | 3,175,000 |
| Inventories | 153,000 | 117,000 | 202,000 | 949,000 | 1,441,000 |
| TOTAL | $6,544,000 | $8,099,000 | $10,325,000 | $13,431,000 | $16,071,000 |
| Non-Current Assets | |||||
| PPE Net | 2,134,000 | 2,196,000 | 1,945,000 | 2,018,000 | 1,241,000 |
| Investments And Advances | 2,336,000 | 2,494,000 | 4,677,000 | 8,318,000 | 6,843,000 |
| Other Non-Current Assets | 1,324,000 | 1,353,000 | 1,479,000 | 2,091,000 | 514,000 |
| TOTAL | $5,794,000 | $6,043,000 | $8,101,000 | $12,427,000 | $8,598,000 |
| Total Assets | $12,338,000 | $14,142,000 | $18,426,000 | $25,858,000 | $24,669,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 317,000 | 405,000 | 520,000 | 487,000 | 302,000 |
| Accrued Expenses | 1,386,000 | 1,427,000 | 1,798,000 | 2,101,000 | 1,472,000 |
| Other current liabilities | 185,000 | 221,000 | 129,000 | 249,000 | 225,000 |
| TOTAL | $1,987,000 | $2,206,000 | $3,015,000 | $4,923,000 | $9,128,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 590,000 | 0 | N/A | N/A | N/A |
| Deferred Revenues | 99,000 | 153,000 | 568,000 | 2,038,000 | 6,253,000 |
| Other Non-Current Liabilities | 938,000 | 938,000 | 899,000 | 227,000 | 182,000 |
| TOTAL | $1,701,000 | $1,035,000 | $1,557,000 | $1,812,000 | $1,396,000 |
| Total Liabilities | $3,688,000 | $3,241,000 | $4,572,000 | $6,735,000 | $10,524,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 394,939 | 385,816 | 382,073 | 386,340 | 402,873 |
| Retained earnings | 7,223,000 | 10,045,000 | 13,606,000 | 18,320,000 | 9,958,000 |
| Other shareholders' equity | 45,000 | -10,000 | -123,000 | -370,000 | -24,000 |
| TOTAL | $8,650,000 | $10,901,000 | $13,854,000 | $19,123,000 | $14,145,000 |
| Total Liabilities And Equity | $12,338,000 | $14,142,000 | $18,426,000 | $25,858,000 | $24,669,000 |